These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1264656)

  • 41. Resolution of gouty tophi after twelve weeks of pegloticase treatment.
    Baraf HS; Matsumoto AK; Maroli AN; Waltrip RW
    Arthritis Rheum; 2008 Nov; 58(11):3632-4. PubMed ID: 18975338
    [No Abstract]   [Full Text] [Related]  

  • 42. A preliminary report of nephropathy in hyperuricemic rats.
    Waisman J; Bluestone R; Klinenberg JR
    Lab Invest; 1974 Jun; 30(6):716-22. PubMed ID: 4835598
    [No Abstract]   [Full Text] [Related]  

  • 43. [Study of the action of fungal urate oxidase on uricemia and excretion of uric nitrogen in man].
    Royer R; Lamarche M; Kissel P
    Therapie; 1967; 22(5):1113-25. PubMed ID: 5583620
    [No Abstract]   [Full Text] [Related]  

  • 44. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
    Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute renal failure as a complication of treatment of acute leukemia].
    Tomicki A
    Wiad Lek; 1974 Sep; 27(17):1565-8. PubMed ID: 4408492
    [No Abstract]   [Full Text] [Related]  

  • 46. [Allopurinol in the prevention and treatment of urate complications in leukemia].
    Aldo C; Roberto M
    Haematologica; 1969; 54(1):17-28. PubMed ID: 4978717
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of allopurinol for control of hyperuricemia in leukemia and lymphoma.
    DeConti RC; Calabresi P
    Conn Med; 1967 Jun; 30(6):430-6. PubMed ID: 6046076
    [No Abstract]   [Full Text] [Related]  

  • 48. [Uric acid determination using uricase-peroxidase system].
    Makino Y; Konno K
    Rinsho Byori; 1967 Feb; 15(2):148-51. PubMed ID: 6069420
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of patients with acute nonlymphocytic leukemia not in remission.
    Grever MR
    Semin Oncol; 1987 Dec; 14(4):416-24. PubMed ID: 3321446
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy.
    Poznansky MJ
    Life Sci; 1979 Jan; 24(2):153-8. PubMed ID: 763074
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunological aspects of urate oxidase therapy in hyperuricaemia.
    Fitzpatrick DA; FitzGerald O; McGeeney KF
    Ir J Med Sci; 1977 Jun; 146(6):155-61. PubMed ID: 608828
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of leukemia in pregnancy, based on the analysis of actual cases].
    Jakó J; Kiss A; Telek B; Nagy P; Rák K
    Orv Hetil; 1978 Dec; 119(53):3249-54. PubMed ID: 733242
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug-induced liver diseases in children with acute leukemia].
    Kisliak NS; Vaganov PD
    Vopr Okhr Materin Det; 1978 Sep; 23(9):22-7. PubMed ID: 716283
    [No Abstract]   [Full Text] [Related]  

  • 54. Esophageal stricture encountered during treatment of acute leukemia.
    Karnak I; Senocak ME; Büyükpamukçu N
    J Pediatr Gastroenterol Nutr; 2001 Jan; 32(1):100-2. PubMed ID: 11176336
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyperuricemic uveitis.
    Jain IS; Kaul RL; Jain GC; Munjal VP
    Indian J Ophthalmol; 1977 Oct; 25(3):27-8. PubMed ID: 614269
    [No Abstract]   [Full Text] [Related]  

  • 56. Editorial comment: more on the treatment of acute leukemia.
    Nyhan WL
    J Pediatr; 1966 Oct; 69(4):668-9. PubMed ID: 5921347
    [No Abstract]   [Full Text] [Related]  

  • 57. Leukaemia and related conditions and the blood-uric-acid.
    HICKLING RA
    Lancet; 1958 Jan; 1(7013):175-8. PubMed ID: 13503248
    [No Abstract]   [Full Text] [Related]  

  • 58. [Letter: Prevention of hyperuricemic complications caused by treatment of acute leukemia].
    Sebahoun G; Carcassonne Y
    Nouv Presse Med; 1976 Jan; 5(3):146. PubMed ID: 1264656
    [No Abstract]   [Full Text] [Related]  

  • 59. [Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase].
    Oberling F; Lang JM
    Nouv Presse Med; 1974 Sep; 3(32):2026. PubMed ID: 4530260
    [No Abstract]   [Full Text] [Related]  

  • 60. [Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].
    Vigo P; Ortolani S; Soldati L; Girardello R; Fleischmann L; Polli EE
    Haematologica; 1981 Oct; 66(5):656-66. PubMed ID: 6796473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.